Joanne Jeter

510 total citations
11 papers, 69 citations indexed

About

Joanne Jeter is a scholar working on Molecular Biology, Oncology and Dermatology. According to data from OpenAlex, Joanne Jeter has authored 11 papers receiving a total of 69 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Oncology and 2 papers in Dermatology. Recurrent topics in Joanne Jeter's work include CRISPR and Genetic Engineering (2 papers), CAR-T cell therapy research (2 papers) and Immunotherapy and Immune Responses (2 papers). Joanne Jeter is often cited by papers focused on CRISPR and Genetic Engineering (2 papers), CAR-T cell therapy research (2 papers) and Immunotherapy and Immune Responses (2 papers). Joanne Jeter collaborates with scholars based in United States, Norway and South Korea. Joanne Jeter's co-authors include Utkarsh Acharya, Wendy Kohlmann, Hubert G. Bartels, Vaia Florou, Ignacio Garrido‐Laguna, Theresa L. Werner, Llana Pootrakul, Paul B. Myrdal, Glynn Weldon Gilcrease and Na Hyun Kim and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Frontiers in Oncology.

In The Last Decade

Joanne Jeter

10 papers receiving 66 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joanne Jeter United States 6 35 24 13 13 12 11 69
Neus Calbet‐Llopart Spain 6 31 0.9× 23 1.0× 5 0.4× 16 1.2× 7 0.6× 11 55
Monica Lewis United States 4 14 0.4× 47 2.0× 5 0.4× 13 1.0× 16 1.3× 6 78
Anne Menz Germany 4 18 0.5× 44 1.8× 4 0.3× 11 0.8× 12 1.0× 13 78
Anne Schönle Switzerland 2 26 0.7× 37 1.5× 7 0.5× 20 1.5× 15 1.3× 2 63
F. Trapani Italy 5 21 0.6× 26 1.1× 9 0.7× 9 0.7× 6 0.5× 19 83
Alexander J. Li China 2 20 0.6× 27 1.1× 4 0.3× 14 1.1× 4 0.3× 2 55
Shuqun Zhang China 6 26 0.7× 31 1.3× 2 0.2× 8 0.6× 8 0.7× 9 70
Zane Yang United States 4 40 1.1× 20 0.8× 14 1.1× 13 1.0× 4 0.3× 6 57
Alexis Jiaying Khng Singapore 6 25 0.7× 49 2.0× 20 1.5× 2 0.2× 6 0.5× 13 85
María García‐Beccaria Spain 3 19 0.5× 53 2.2× 4 0.3× 7 0.5× 11 0.9× 3 88

Countries citing papers authored by Joanne Jeter

Since Specialization
Citations

This map shows the geographic impact of Joanne Jeter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanne Jeter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanne Jeter more than expected).

Fields of papers citing papers by Joanne Jeter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joanne Jeter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanne Jeter. The network helps show where Joanne Jeter may publish in the future.

Co-authorship network of co-authors of Joanne Jeter

This figure shows the co-authorship network connecting the top 25 collaborators of Joanne Jeter. A scholar is included among the top collaborators of Joanne Jeter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joanne Jeter. Joanne Jeter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Kim, Na Hyun, Joanne Jeter, Carlo M. Contreras, et al.. (2024). Hedgehog pathway inhibitors for locally advanced and metastatic basal cell carcinoma: A real-world single-center retrospective review. PLoS ONE. 19(4). e0297531–e0297531. 8 indexed citations
2.
Hodan, Rachel, Linda Rodgers, Sanjeevani Arora, et al.. (2023). Current chemoprevention approaches in Lynch syndrome and Familial adenomatous polyposis: a global clinical practice survey. Frontiers in Oncology. 13. 1141810–1141810. 6 indexed citations
3.
Fadlullah, Muhammad Zaki Hidayatullah, Magdalena Kovacsovics, Umang Swami, et al.. (2023). High dose ipilimumab (Ipi) plus temozolomide (TMZ) after progression on standard or low dose Ipi in advanced melanoma.. Journal of Clinical Oncology. 41(16_suppl). 9557–9557. 1 indexed citations
4.
Oh, Mok, Ali McBride, Sandipan Bhattacharjee, et al.. (2023). Economic value of knowing BRCA status: BRCA testing for prostate cancer prevention and optimal treatment. Expert Review of Pharmacoeconomics & Outcomes Research. 23(3). 297–307. 1 indexed citations
5.
Greenberg, Samantha, Wendy Kohlmann, Joanne Jeter, et al.. (2022). Discrepancies between tumor genomic profiling and germline genetic testing. ESMO Open. 7(4). 100526–100526. 10 indexed citations
6.
Kohlmann, Wendy, et al.. (2022). Considerations for Germline Testing in Melanoma: Updates in Behavioral Change and Pancreatic Surveillance for Carriers of CDKN2A Pathogenic Variants. Frontiers in Oncology. 12. 837057–837057. 8 indexed citations
7.
Gammon, Amanda, et al.. (2022). Non-Melanoma Skin Cancers and Other Cutaneous Manifestations in Bone Marrow Failure Syndromes and Rare DNA Repair Disorders. Frontiers in Oncology. 12. 837059–837059. 3 indexed citations
8.
9.
Sundararajan, Srinath, et al.. (2016). Effect of histological subtype on overall survival in cutaneous melanoma: A Surveillance, Epidemiology, and End Result program (SEER) database review.. Journal of Clinical Oncology. 34(15_suppl). e21051–e21051. 1 indexed citations
10.
Jeter, Joanne, Clara Curiel‐Lewandrowski, Steven P. Stratton, et al.. (2015). Phase IIB Randomized Study of Topical Difluoromethylornithine and Topical Diclofenac on Sun-Damaged Skin of the Forearm. Cancer Prevention Research. 9(2). 128–134. 16 indexed citations
11.
Jeter, Joanne & Utkarsh Acharya. (2013). Use of ipilimumab in the treatment of melanoma. Clinical Pharmacology Advances and Applications. 5(Suppl 1). 21–21. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Neus Calbet‐Llopart Breakdown of academic impact, for papers by Monica Lewis Breakdown of academic impact, for papers by Anne Menz Breakdown of academic impact, for papers by Anne Schönle Breakdown of academic impact, for papers by F. Trapani Breakdown of academic impact, for papers by Alexander J. Li Breakdown of academic impact, for papers by Shuqun Zhang Breakdown of academic impact, for papers by Zane Yang Breakdown of academic impact, for papers by Alexis Jiaying Khng Breakdown of academic impact, for papers by María García‐Beccaria
Rankless by CCL
2026